Surgery Partners' $6B Buyout Highlights Healthcare's Decentralized Shift

BRENTWOOD, Tenn. – November 09, 2026

Just as the legacy power grid is being unbundled into resilient, localized microgrids, the traditional acute-care hospital is undergoing its own structural revolution. The sprawling, centralized medical centers of the past are increasingly giving way to nimble, decentralized nodes of care: short-stay, high-efficiency ambulatory surgery centers (ASCs).

This transition from centralized vulnerability to decentralized resilience was placed in stark financial relief on Monday, when Surgery Partners, Inc. (NASDAQ: SGRY) announced a sweetened $6.0 billion merger agreement with HealthSpan Partners, an affiliate of Bon Secours Mercy Health. The all-cash $25.00 per share offer comes on the heels of a fierce, unsolicited bidding war that perfectly illustrates the massive premium private capital and strategic buyers are placing on decentralized healthcare infrastructure.

A Bidding War for the "Microgrids" of Healthcare

The drama surrounding Surgery Partners is a textbook case of market forces recognizing the value of high-acuity, low-cost real estate. HealthSpan Partners initially struck a deal in late October to acquire the Brentwood, Tennessee-based operator for $23.50 per share. But the ink was barely dry before an unsolicited third party swooped in with a towering $28.00 per share cash offer.

Market insiders have since identified the mystery bidder as healthcare behemoth UnitedHealth Group. Yet, in a fascinating display of risk-adjusted decision-making, Surgery Partners' Special Committee rejected the higher $28.00 bid in favor of HealthSpan's revised $25.00 offer.

Why leave money on the table? Regulatory resilience. In a climate where federal antitrust regulators at the Federal Trade Commission (FTC) and the Department of Justice (DOJ) are aggressively scrutinizing healthcare monopolies, a UnitedHealth acquisition carried immense closing risks. The Special Committee correctly calculated that a prolonged, legally fraught regulatory battle with Washington was a liability. HealthSpan, while still subject to regulatory review, offered a much clearer, more certain path to the finish line.

The Ticking Fee and Bain Capital's Play

To compensate shareholders for the lower headline price and to guarantee execution, HealthSpan introduced a fascinating structural mechanism: a "Ticking Fee." If the deal secures the requisite stockholder approval but fails to close by March 1, 2027, stockholders will receive monthly cash payments. Paid in arrears, this fee accrues at a rate of 10% per annum on the $25.00 base price. If the merger is pushed to its ultimate outside date of October 2027, this ticking fee could add up to $1.61 per share, bringing the maximum consideration to $26.61.

However, there is a notable exception to this payout. Bain Capital Private Equity, Surgery Partners' largest stockholder with a roughly 39% stake, is excluded from both the cash merger consideration and the ticking fee. Instead, the private equity giant is rolling over its shares in exchange for equity interests in the new acquiring entity. Bain, which previously attempted to buy out the remainder of the company for $25.75 a share in early 2025, will remain a significant partner post-closing. Their willingness to roll over equity signals a deep, long-term conviction in the secular tailwinds driving the ASC market.

Pruning the Centralized Model: The Idaho Falls Divestiture

Surgery Partners' third-quarter 2026 financial results, released concurrently with the merger amendment, offer a clear look under the hood of this decentralized strategy.

At first glance, the top-line numbers appear muted. Revenues for the third quarter decreased 0.8% year-over-year to $815.3 million, and the company reported a net loss attributable to stockholders of $21.1 million. However, these figures are the direct result of a calculated structural pruning. On September 13, 2026, Surgery Partners completed the divestiture of its Idaho Falls facilities—including Mountain View Hospital and Idaho Falls Community Hospital—to Intermountain Health for $587 million in net cash proceeds.

By shedding these bulky, centralized acute-care assets, Surgery Partners is accelerating its transformation into a pure-play, short-stay surgical provider. The operational streamlining is severe but strategic. Excluding the Idaho Falls facilities, the company expects a 50% reduction in its Medicaid payer mix, a 50% reduction in intensive care beds, and the complete elimination of peripheral service lines like neonatology, obstetrics, and retail pharmacies.

The underlying metrics of the remaining decentralized network are thriving. Same-facility revenues for the third quarter increased 6.0% compared to the prior year, driven by a highly efficient 5.8% increase in revenue per case and a 0.2% uptick in case volume. Adjusted EBITDA remained robust at $132.7 million.

"Our financial results in the third quarter reflect the impact of the successful Idaho Falls divestiture and sustained momentum in our core business, underscoring the value of our short-stay surgical platform," stated Eric Evans, Chief Executive Officer of Surgery Partners. "Additionally, the recently announced amended merger agreement with HealthSpan Partners serves as further validation of our unique offering, while representing a compelling outcome for our patients, physicians, stockholders, and other stakeholders."

Regulatory Headwinds in a Consolidating Market

As Surgery Partners prepares to transition from the public markets to the private sector—suspending its earnings calls and forward-looking guidance in the process—the broader industry is watching closely. The combination of HealthSpan Partners and Surgery Partners will create one of the largest outpatient surgical care platforms in the United States, operating more than 200 locations across 30 states.

Federal regulators have historically prioritized antitrust enforcement in the healthcare sector, viewing competition as essential to controlling costs. Recent DOJ actions against large hospital systems for alleged anti-competitive contracting practices indicate a continued focus on ensuring competitive markets. Regulators will undoubtedly examine whether the merger increases market concentration in specific geographic areas and whether the combined entity would have undue leverage to raise prices.

Yet, the strategic rationale for the merger remains ironclad. Just as the global economy is realizing that decentralized energy grids offer superior security and efficiency, the healthcare sector is acknowledging that ambulatory surgery centers offer superior margins, lower infection rates, and reduced costs compared to legacy hospital systems. For Bon Secours Mercy Health, acquiring Surgery Partners is not just an expansion; it is an essential modernization of its infrastructure to survive the industry-wide shift toward value-based care.

The $6 billion battle for Surgery Partners is more than a standard Wall Street buyout. It is a definitive signal that the future of healthcare, much like the future of global power, belongs to the decentralized, the efficient, and the resilient.